We are live on
!
Find out more
AAP
Ardsley Advisory Partners Portfolio holdings
AUM
$960M
1-Year Est. Return
207.76%
This Fund
S&P 500
This Quarter
Est. Return
+4.4%
1 Year Est. Return
+207.76%
3 Year Est. Return
+554.53%
5 Year Est. Return
+728.66%
10 Year Est. Return
+4,084.52%
AUM
$667M
AUM Growth
-$156M
(-19%)
Cap. Flow
+$83.2M
Cap. Flow
% of AUM
12.47%
Top 10 Holdings %
Top 10 Hldgs %
36.65%
Holding
203
New
66
Increased
38
Reduced
28
Closed
61
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
|
+$42.5M |
| 2 |
CELG
Celgene Corp
CELG
|
+$21.6M |
| 3 |
Elevance Health
ELV
|
+$18.4M |
| 4 |
Sunrun
RUN
|
+$13.1M |
| 5 |
Ashland
ASH
|
+$9.72M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$20.1M |
| 2 |
NSM
Nationstar Mortgage Holdings
NSM
|
+$11.6M |
| 3 |
Macerich
MAC
|
+$11.6M |
| 4 |
NGD
New Gold Inc
NGD
|
+$10.4M |
| 5 |
Hannon Armstrong Sustainable Infrastructure Capital
HASI
|
+$9.42M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.53% |
| 2 | Miscellaneous | 21.87% |
| 3 | Technology | 20.83% |
| 4 | Utilities | 9.14% |
| 5 | Materials | 6.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$312M
| $43.9M | 6.57% |
1,210,000
+1,145,000
| +1,762% | +$42.5M |
|
|
AY
2
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
| $37.4M | 5.61% |
1,911,196
+21,396
| +1% | +$434K |
|
3
CALL
ProShares UltraShort Health Care
RXD
$3.29M
| $27.2M | 4.08% |
187,500
-262,500
| -58% | -$29.5M |
|
|
4
Sunrun
RUN
$2.06B
| $24.8M | 3.72% |
2,783,550
+1,938,350
| +229% | +$13.1M |
|
5
State Street SPDR S&P Biotech ETF
XBI
$10.9B
| $20.9M | 3.14% |
238,500
-39,000
| -14% | -$3.56M |
|
|
CELG
6
DELISTED
Celgene Corp
CELG
| $20M | 3% |
+224,500
| New | +$21.6M |
|
|
STKL
7
DELISTED
SunOpta
STKL
| $18.7M | 2.8% |
2,651,801
+103,401
| +4% | +$768K |
|
|
CELG
8
CALL
DELISTED
Celgene Corp
CELG
| $17.8M | 2.67% |
+200,000
| New | +$19.2M |
|
|
9
Elevance Health
ELV
$90.8B
| $17.2M | 2.58% |
+78,500
| New | +$18.4M |
|
10
Centene
CNC
$32.8B
| $16.5M | 2.47% |
309,000
+59,000
| +24% | +$3.08M |
|
11
Microsoft
MSFT
$3.68T
| $16.4M | 2.46% |
180,000
+40,000
| +29% | +$3.66M |
|
12
FTAI Aviation
FTAI
$19.1B
| $16.4M | 2.46% |
1,203,203
+348,373
| +41% | +$5.13M |
|
|
ALXN
13
DELISTED
Alexion Pharmaceuticals
ALXN
| $16.4M | 2.46% |
147,000
-37,000
| -20% | -$4.42M |
|
14
Jazz Pharmaceuticals
JAZZ
$16B
| $16M | 2.4% |
106,000
-5,000
| -5% | -$733K |
|
|
PGNX
15
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $15.9M | 2.38% |
2,130,000
+300,000
| +16% | +$1.99M |
|
16
Golar LNG
GLNG
$5.4B
| $14.2M | 2.13% |
520,000
-67,500
| -11% | -$1.9M |
|
|
EVA
17
DELISTED
Enviva Inc.
EVA
| $13.3M | 1.99% |
484,872
+21,451
| +5% | +$588K |
|
18
Adobe
ADBE
$100B
| $13.3M | 1.99% |
61,500
+500
| +0.8% | +$102K |
|
|
MBII
19
DELISTED
Marrone Bio Innovations, Inc.
MBII
| $12.7M | 1.91% |
10,348,247
+6,666,667
| +181% | +$8.94M |
|
|
FLXN
20
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $11.7M | 1.75% |
520,000
+105,000
| +25% | +$2.56M |
|
|
21
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.8B
| $10.5M | 1.58% |
540,000
-462,500
| -46% | -$9.42M |
|
22
Palo Alto Networks
PANW
$270B
| $9.53M | 1.43% |
315,000
+273,000
| +650% | +$7.58M |
|
|
23
Ashland
ASH
$3.25B
| $9.42M | 1.41% |
+135,000
| New | +$9.72M |
|
|
24
CALL
Golar LNG
GLNG
$5.4B
| $8.89M | 1.33% |
325,000
-75,000
| -19% | -$2.12M |
|
25
Bunge Global
BG
$23.5B
| $8.87M | 1.33% |
120,000
+102,500
| +586% | +$7.74M |
|
Similar funds
RAM
JWBC
PL
SCM
LGP
WI
LAM
ACP
Ardsley Advisory Partners's Q1 2018 Portfolio in Review
As of Q1 2018, Ardsley Advisory Partners held 203 positions worth $667M, down 19% from $823M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Ardsley Advisory Partners deployed $83.2M of net new capital in Q1 2018, opening 66 new positions and adding to 38 existing holdings. Its largest new stake was Celgene Corp: 224,500 shares worth $20M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 17% a quarter earlier, followed by Miscellaneous and Technology.
On the sell side, the largest reduction was Macerich, an estimated $11.6M trimmed.
- Ardsley Advisory Partners's largest Q1 2018 buy was Celgene Corp: 224,500 shares worth $20M.
- Ardsley Advisory Partners added most to ProShares Trust UltraShort Lehman 20+ Year Treasury in Q1 2018, an estimated $42.5M increase.
- Ardsley Advisory Partners's biggest Q1 2018 reduction was Macerich, cutting an estimated $11.6M.
- Ardsley Advisory Partners fully exited AbbVie in Q1 2018, selling an estimated $20.1M.
- Ardsley Advisory Partners's ten largest holdings make up 37% of its $667M portfolio in Q1 2018.
- Ardsley Advisory Partners opened 66 new positions and closed 61 in Q1 2018.
- Ardsley Advisory Partners's portfolio value fell 19% quarter-over-quarter to $667M.
Based on Ardsley Advisory Partners's 13F filing for Q1 2018, filed 15 May 2018.